Sandra Horning is Director of Moderna, Inc.. Currently has a direct ownership of 1,373 shares of MRNA, which is worth approximately $54,357. The most recent transaction as insider was on Apr 28, 2023, when has been sold 670 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.37K
0% 3M change
0% 12M change
Total Value Held $54,357

Sandra Horning Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 28 2023
BUY
Exercise of conversion of derivative security
-
670 Added 32.79%
1,373 Common Stock
Apr 28 2022
BUY
Exercise of conversion of derivative security
-
703 Added 50.0%
703 Common Stock

Also insider at

OLMA
Olema Pharmaceuticals, Inc. Healthcare
GILD
GILEAD SCIENCES, INC. Healthcare
RVMD
Revolution Medicines, Inc. Healthcare
EQRX
EQRx, Inc. Healthcare
SH

Sandra Horning

Director
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Track Activities on MRNA